Adviteeya Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.95 Cr
- Revenue Growth 75.99%
- Profit Growth 11.04%
- Ebitda -329.47%
- Net Worth 264.18%
- Total Assets 112.91%
About Adviteeya Pharma
Adviteeya Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2016 (Eight years and nine months 30 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.95 Cr.
Prasad Mallisetty and Usha Damera serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299TG2016PTC109191
- Company No.
109191
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Adviteeya Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Usha Damera  | Managing Director | 25-Apr-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasad Mallisetty | Director | 25-Apr-2016 | Current |
Financial Performance of Adviteeya Pharma.
Adviteeya Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 75.99% increase. The company also saw a substantial improvement in profitability, with a 11.04% increase in profit. The company's net worth Soared by an impressive increase of 264.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adviteeya Pharma?
In 2021, Adviteeya Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹19.50 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2021 | Axis Bank Limited | ₹1.95 Cr | Open |
How Many Employees Work at Adviteeya Pharma?
Adviteeya Pharma has a workforce of 3 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adviteeya Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adviteeya Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.